Published in J Neurosci on November 25, 2009
Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J Neurosci (2011) 1.59
Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma (2012) 1.41
Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci (2011) 1.25
Corticospinal reorganization after spinal cord injury. J Physiol (2012) 1.17
Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One (2012) 1.14
Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials (2011) 1.13
Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes. Invest Ophthalmol Vis Sci (2011) 1.06
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med (2011) 1.03
A reassessment of whether cortical motor neurons die following spinal cord injury. J Comp Neurol (2011) 1.03
Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cells. Knee Surg Sports Traumatol Arthrosc (2011) 1.02
7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One (2014) 1.01
Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med (2013) 0.96
Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One (2011) 0.93
Wallerian degeneration in central nervous system: dynamic associations between diffusion indices and their underlying pathology. PLoS One (2012) 0.90
Localized delivery of brain-derived neurotrophic factor-expressing mesenchymal stem cells enhances functional recovery following cervical spinal cord injury. J Neurotrauma (2014) 0.88
Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res Ther (2014) 0.87
Clinical and experimental advances in regeneration of spinal cord injury. J Tissue Eng (2010) 0.87
Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PLoS One (2013) 0.86
Endogenous proliferation after spinal cord injury in animal models. Stem Cells Int (2012) 0.85
Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury. Stem Cells Transl Med (2016) 0.85
BDNF treatment and extended recovery from optic nerve trauma in the cat. Invest Ophthalmol Vis Sci (2013) 0.84
Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions. Stem Cells Int (2015) 0.83
Beneficial effect of interleukin-1 receptor antagonist protein on spinal cord injury recovery in the rat. Inflammation (2012) 0.83
Long-term production of BDNF and NT-3 induced by A91-immunization after spinal cord injury. BMC Neurosci (2016) 0.82
Neuroprotective effect of rapamycin on spinal cord injury via activation of the Wnt/β-catenin signaling pathway. Neural Regen Res (2015) 0.82
Brain-derived neurotrophic factor from bone marrow-derived cells promotes post-injury repair of peripheral nerve. PLoS One (2012) 0.82
Stem cell therapy for glaucoma: possibilities and practicalities. Expert Rev Ophthalmol (2011) 0.81
Dendritic spine dysgenesis contributes to hyperreflexia after spinal cord injury. J Neurophysiol (2014) 0.80
Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy? Neural Regen Res (2015) 0.80
Gene delivery strategies to promote spinal cord repair. Biomark Insights (2015) 0.79
Collagen-glycosaminoglycan matrix implantation promotes angiogenesis following surgical brain trauma. Biomed Res Int (2014) 0.79
Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Res Ther (2015) 0.78
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Comparison of viability and antioxidant capacity between canine adipose-derived mesenchymal stem cells and heme oxygenase-1-overexpressed cells after freeze-thawing. J Vet Med Sci (2015) 0.77
PSA-NCAM positive neural progenitors stably expressing BDNF promote functional recovery in a mouse model of spinal cord injury. Stem Cell Res Ther (2016) 0.77
Bone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury. J Neurotrauma (2015) 0.76
Effects on Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells Engineered to Express Neurotrophic Factors. Stem Cells Int (2015) 0.76
Mesenchymal stem cells as a novel vaccine platform. Front Cell Infect Microbiol (2012) 0.76
Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism. Tissue Eng Part A (2014) 0.76
Chondroitinase administration and pcDNA3.1-BDNF-BMSC transplantation promote motor functional recovery associated with NGF expression in spinal cord-transected rat. Spinal Cord (2016) 0.76
A Proposal for a Rat Model of Spinal Cord Injury Featuring the Rubrospinal Tract and its Contributions to Locomotion and Skilled Hand Movement. Front Neurosci (2016) 0.75
Stem Cells and Labeling for Spinal Cord Injury. Int J Mol Sci (2016) 0.75
Analgesic mechanism of electroacupuncture in a rat L5 spinal nerve ligation model. Exp Ther Med (2015) 0.75
Gastrodin promotes the secretion of brain-derived neurotrophic factor in the injured spinal cord. Neural Regen Res (2013) 0.75
Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke. Oxid Med Cell Longev (2016) 0.75
Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int J Mol Sci (2017) 0.75
Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. Front Neurosci (2017) 0.75
Neuropeptide expression and morphometric differences in crushed alveolar inferior nerve of rats: Effects of photobiomodulation. Lasers Med Sci (2017) 0.75
The Neuroprotective Effects of Muscle-Derived Stem Cells via Brain-Derived Neurotrophic Factor in Spinal Cord Injury Model. Biomed Res Int (2017) 0.75
Stem cell transplantation for spinal cord injury: a meta-analysis of treatment effectiveness and safety. Neural Regen Res (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 17.06
A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48
Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell (2001) 12.42
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res (2000) 7.87
The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS (1988) 6.75
From marrow to brain: expression of neuronal phenotypes in adult mice. Science (2000) 6.53
The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci (2004) 5.36
Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A (1999) 5.20
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci (2003) 4.60
Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol (2000) 4.56
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45
Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts. Proc Natl Acad Sci U S A (1998) 4.13
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol (1998) 3.08
Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol (2005) 2.97
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A (2008) 2.70
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 2.49
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant (2007) 2.47
Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology (2002) 2.38
Precursor cells of mechanocytes. Int Rev Cytol (1976) 2.28
A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res (2004) 2.11
Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci (2006) 1.99
Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience (2005) 1.95
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther (2004) 1.87
The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci (2006) 1.77
BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol (2005) 1.75
I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience (2005) 1.70
Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair (2006) 1.66
Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp Neurol (1998) 1.56
Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation (2008) 1.51
Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol (2004) 1.47
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain (2006) 1.46
Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol (2006) 1.44
Anatomical changes in human motor cortex and motor pathways following complete thoracic spinal cord injury. Cereb Cortex (2008) 1.43
Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury. J Comp Neurol (2003) 1.43
Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci U S A (2002) 1.36
BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain (2006) 1.34
Neurotrophins and their receptors in nerve injury and repair. Neurochem Int (1997) 1.33
Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol (2003) 1.29
Remodeling of synaptic structures in the motor cortex following spinal cord injury. Exp Neurol (2006) 1.28
Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol (2006) 1.28
Stereological estimation of the total number of neurons in the murine hippocampus using the optical disector. J Comp Neurol (1999) 1.26
Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma (2000) 1.22
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab (2007) 1.21
Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis. Cell Transplant (2000) 1.21
Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci (2001) 1.17
The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury. J Neurosci (2008) 1.17
Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J Neurosci (2008) 1.15
Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci (2005) 1.15
Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci (2004) 1.09
Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury. J Neurosci Res (2003) 1.08
Protection of corticospinal tract neurons after dorsal spinal cord transection and engraftment of olfactory ensheathing cells. Glia (2006) 1.07
Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant (1996) 1.01
Brain-derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant. J Neurosci Res (2002) 1.00
Neuron numbers in the superior cervical sympathetic ganglion of the rat: a critical comparison of methods for cell counting. J Neurocytol (1983) 1.00
Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine (Phila Pa 1976) (2007) 1.00
Up-regulation of 5-HT2 receptors is involved in the increased H-reflex amplitude after contusive spinal cord injury. Exp Neurol (2006) 0.97
Bone marrow stromal cells promote neurite extension in organotypic spinal cord slice: significance for cell transplantation therapy. Neurorehabil Neural Repair (2008) 0.97
Fetal spinal cord transplants rescue some axotomized rubrospinal neurons from retrograde cell death in adult rats. Exp Neurol (1997) 0.95
Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J Neuropathol Exp Neurol (2005) 0.95
Reduction of cystic cavity, promotion of axonal regeneration and sparing, and functional recovery with transplanted bone marrow stromal cell-derived Schwann cells after contusion injury to the adult rat spinal cord. J Neurosurg Spine (2008) 0.90
Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J (2007) 0.90
Axonal branching patterns and funicular trajectories of raphespinal sympathoinhibitory neurons. J Neurophysiol (1985) 0.89
Injury in the spinal cord may produce cell death in the brain. Brain Res (2004) 0.87
Prelabeled red nucleus and sensorimotor cortex neurons of the rat survive 10 and 20 weeks after spinal cord transection. J Neuropathol Exp Neurol (1989) 0.86
Adenovirus-mediated delivery of GDNF ameliorates corticospinal neuronal atrophy and motor function deficits in rats with spinal cord injury. Neuroreport (2004) 0.86
Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury. J Korean Med Sci (2004) 0.83
Subspecies of protein kinase C in the rat spinal cord. Prog Neurobiol (1998) 0.81
RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell (2009) 11.12
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature (2007) 4.63
Moyamoya disease: current concepts and future perspectives. Lancet Neurol (2008) 3.35
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res (2008) 3.20
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64
Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood (2005) 2.60
A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res (2004) 2.11
A Survey of Chronic Pain Due to Spinal Dural Arteriovenous Fistulae. Neurosurgery (2015) 2.03
The multi-ethnic pediatric eye disease study: design and methods. Ophthalmic Epidemiol (2006) 2.02
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther (2005) 1.91
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther (2004) 1.87
Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci (2002) 1.75
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci (2006) 1.74
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain (2011) 1.73
Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis. Neurosurg Rev (2010) 1.69
Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia (2002) 1.68
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci (2005) 1.68
Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation (2005) 1.65
White matter hyperintensities and dynamics of postural control. Magn Reson Imaging (2009) 1.60
Performance of bipolar forceps during coagulation and its dependence on the tip material: a quantitative experimental assay. Technical note. J Neurosurg (2004) 1.55
Increased expression of vascular endothelial growth factor and its receptor in enlarging brain arteriovenous malformations--a case report. Br J Neurosurg (2013) 1.50
Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease. World Neurosurg (2012) 1.48
Incidence and clinical features of disease progression in adult moyamoya disease. Stroke (2005) 1.47
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2008) 1.44
Role of IL-10-Producing Regulatory B Cells in Chronic Hepatitis B Virus Infection. Dig Dis Sci (2014) 1.44
Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg (2005) 1.44
Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J Cell Biol (2011) 1.42
Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol (2005) 1.39
Comment on: Percutaneous Aponeurotomy and Lipofilling (PALF) versus Limited Fasciectomy in Patients with Primary Dupuytren's Contracture: A Prospective, Randomized, Controlled Trial. Plast Reconstr Surg (2017) 1.38
Supervised learning-based cell image segmentation for p53 immunohistochemistry. IEEE Trans Biomed Eng (2006) 1.36
A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer (2009) 1.35
Nonlinear assessment of cerebral autoregulation from spontaneous blood pressure and cerebral blood flow fluctuations. Cardiovasc Eng (2008) 1.35
Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J Mol Cell Cardiol (2009) 1.33
Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma (2007) 1.33
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One (2012) 1.31
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci (2004) 1.30
Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol (2003) 1.29
Human health risk from soil heavy metal contamination under different land uses near Dabaoshan Mine, Southern China. Sci Total Environ (2012) 1.29
Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J Clin Invest (2010) 1.28
Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol (2008) 1.27
Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res (2006) 1.27
Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem (2005) 1.26
Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther (2004) 1.26
Identification and characterization of two splice variants of human diacylglycerol kinase eta. J Biol Chem (2003) 1.25
Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res (2010) 1.22
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab (2007) 1.21
A quantitative morphometric analysis of rat spinal cord remyelination following transplantation of allogenic Schwann cells. J Comp Neurol (2002) 1.20
Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care (2011) 1.18
Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells (2006) 1.16
Soil microbial biomass, basal respiration and enzyme activity of main forest types in the Qinling Mountains. PLoS One (2013) 1.16
Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem Biophys Res Commun (2012) 1.16
Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J Neurosci (2008) 1.15
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol (2009) 1.15
Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J Virol (2003) 1.13
In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging (2004) 1.13
Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Mol Cancer Ther (2007) 1.13
Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature. J Neurooncol (2010) 1.13
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther (2003) 1.13
The volumetric analysis of fat graft survival in breast reconstruction. Plast Reconstr Surg (2013) 1.12
Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol (2002) 1.09
Clinical features and pathomechanisms of syringomyelia associated with spinal arachnoiditis. Surg Neurol (2005) 1.09
Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci (2004) 1.09
De novo follicular regeneration of the skin by wingless int 3 and bone morphogenetic protein 2 genes introduced into dermal fibroblasts and fibroblast growth factor-2 protein. Wound Repair Regen (2009) 1.08
IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS One (2013) 1.08
Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med (2012) 1.08
Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) (2011) 1.08
Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol (2008) 1.08
Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res (2008) 1.08